Clinical trial
Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
NCT00137111 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00137111 |
|---|---|
| Title | Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia |
| Official title | Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoblastic Leukemia, Acute |
| Intervention type | Drug, Procedure |
| Interventions | Prednisone, Dexamethasone, Vincristine, Daunorubicin, Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase, Methotrexate, Cyclophosphamide and 8 more |
| Enrollment | 501 |
| Start date | Jul 8, 2000 |
| Primary completion | Nov 1, 2010 |
| Completion | Apr 1, 2014 |
| First posted | Aug 29, 2005 |
| Last update posted | Sep 11, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: